TITLE

Electrophysiological and neuropsychological predictors of conversion to schizophrenia in at-risk subjects

AUTHOR(S)
Tomiki Sumiyoshi; Tomohiro Miyanishi; Tomonori Seo; Yuko Higuchi
PUB. DATE
October 2013
SOURCE
Frontiers in Behavioral Neuroscience;Oct2013, Vol. 7, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Patients with schizophrenia show neurophysiological and psychological disturbances before the onset of the illness. Mismatch negativity (MMN), an event-related potential, has been shown to be associated with cognitive function. Specifically, duration MMN (dMMN) amplitudes have been indicated to predict progression to overt schizophrenia in subjects with at-risk mental state. The aim of this article is to provide a hypothesis that a combined assessment of dMMN and neuropsychological performance would enhance accuracy for predicting conversion to schizophrenia in at-risk subjects. Data from these neurocogni-tive modalities in subjects with first-episode schizophrenia (FES) are also presented. There is accumulated evidence that converters to schizophrenia among at-risk subjects show significantly smaller dMMN amplitudes than those in healthy control (HC) subjects at the frontal lead before the onset. In fact, the amplitudes in these converters have been reported to be similar to those in FES to begin with. dMMN current source density, by means of low-resolution brain electromagnetic tomography, was significantly lower in FES than HC subjects, especially in some medial temporal regions which are implicated in the pathophysiology of schizophrenia. Importantly, dMMN current density in the frontal lobe was positively correlated with working memory performance in FES subjects. These findings indicate the utility of the combination of electrophysiological/neuropsychological assessments for early intervention into patients with schizophrenia and high-risk people.
ACCESSION #
97864852

 

Related Articles

  • What do ERPs and ERFs Reveal About the Effect of Antipsychotic Treatment on Cognition in Schizophrenia? Korostenskaja, M.; K�hk�nen, S. // Current Pharmaceutical Design;8/1/2009, Vol. 15 Issue 22, p2573 

    Cognitive dysfunction is considered to be a core feature in schizophrenia. It is believed that antipsychotic drugs, especially atypical ones, could improve cognitive functions in schizophrenia patients. Auditory event-related potentials (ERPs) such as mismatch negativity (MMN) and P300 response...

  • P300 and contingent negative variation in migraine. Feleppa, Michele; Di Iorio, Walter; Saracino, Donato M. T. // Journal of Headache & Pain;Nov 2004 Supplement 2, Vol. 5, ps51 

    We reviewed P300 and contingent negative variation (CNV) studies performed in migraine in order to identify their relevance in migraine and the role of neurophysiology in migraine. Publications available to us were completed by a Medline search. There is experimental and clinical evidence for...

  • The Processing of Causal and Hierarchical Relations in Semantic Memory as Revealed by N400 and Frontal Negativity. Liang, Xiuling; Chen, Qingfei; Lei, Yi; Li, Hong // PLoS ONE;7/6/2015, Vol. 10 Issue 7, p1 

    Most current studies investigating semantic memory have focused on associative (ring-emerald) or taxonomic relations (bird-sparrow). Little is known about the question of how causal relations (virus- epidemic) are stored and accessed in semantic memory. The goal of this study was to examine the...

  • Effects of Auditory Attention Training with the Dichotic Listening Task: Behavioural and Neurophysiological Evidence. Tallus, Jussi; Soveri, Anna; Hämäläinen, Heikki; Tuomainen, Jyrki; Laine, Matti // PLoS ONE;10/6/2015, Vol. 10 Issue 10, p1 

    Facilitation of general cognitive capacities such as executive functions through training has stirred considerable research interest during the last decade. Recently we demonstrated that training of auditory attention with forced attention dichotic listening not only facilitated that performance...

  • The Relationship between Attention/Vigilance and Symptom Severity in Schizophrenic Patients. Jolfaei, Atefeh Ghanbari; Moshki, Pegah; Asgharpour, Mania; Moshki, Hamid // Iranian Journal of Psychiatry;Winter2012, Vol. 7 Issue 1, p22 

    Objective: In schizophrenia, neurocognitive functions are one to two standard deviations below the normal controls and these deficits have a significant relationship with overall functioning and poor outcome. According to this fact, it is important to investigate the factors that effect...

  • Social perception training in schizophrenia: A pilot study. Fuentes, Inmaculada; Garc�a, Sonia; Ruiz, Juan Carlos; Soler, M� Jos�; Roder, Volker // International Journal of Psychology & Psychological Therapy;2007, Vol. 7 Issue 1, p1 

    Social cognition has been recognized as one of the key cognitive factors that is impaired in schizophrenia. The aim of this study was to investigate the possibility of improvements in social perception, which is a key component of social cognition, in chronically ill patients. Eighteen...

  • Déficit cognitivo y esquizofrenia.  // Actas Espanolas de Psiquiatria;ene-feb2001, Vol. 29 Issue 1, p1 

    No abstract available.

  • Neurocognitive basis of insight in schizophrenia. Mysore, Ashok; Parks, Randolph W.; Kwang-Hyuk Lee; Bhaker, Rajinder S.; Birkett, Paul; Woodruff, Peter W. R.; Lee, Kwang-Hyuk // British Journal of Psychiatry;Jun2007, Vol. 190, p529 

    People with schizophrenia have been categorised into three groups: those with full insight (aware, correct attributers); those aware of being unwell, but who misattributed their symptoms (aware, incorrect attributers); and those unaware of being ill (unaware). Cluster analysis of 'awareness of...

  • Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms. Riedel, Michael; Spellmann, Ilja; Strassnig, Martin; Douhet, Anette; Dehning, Sandra; Opgen-Rhein, Markus; Valdevit, Rosamaria; Engel, Rolf R.; Kleindienst, Nikolaus; Müller, Norbert; Möller, Hans-jürgen // European Archives of Psychiatry & Clinical Neuroscience;Sep2007, Vol. 257 Issue 6, p360 

    Evidence suggests that neurocognitive impairment is a key factor in the pathology of schizophrenia and is linked with the negative symptoms of the disease. In this study the effects of the atypical antipsychotics quetiapine and risperidone on cognitive function in patients with schizophrenia and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics